Could a single cell treatment free liver transplant patients from daily anti-rejection pills?
Disease control
Ongoing
This study tests a new treatment called QEL-001, made from a patient's own cells, to help their body accept a donated liver without needing lifelong anti-rejection drugs. About 33 adults who received a liver transplant 1 to 5 years ago will receive the therapy and then try to sto…
Phase: PHASE1, PHASE2 • Sponsor: Quell Therapeutics Limited • Aim: Disease control
Last updated May 15, 2026 11:54 UTC